This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Savage, S. A. Search for Related Content PubMed PubMed Citation Articles by Savage, S. A.

Analysis of Genes Critical for Growth Regulation Identifies Insulin-like Growth Factor 2 Receptor Variations with Possible Functional Significance as Risk Factors for Osteosarcoma

¹ Section of Genomic Variation, Pediatric Oncology Branch and ² Genetics Branch, Center for Cancer Research; ³ Clinical Genetics Branch, ⁴ Epidemiology and Biostatistics Program, and ⁵ Core Genotyping Facility, Division of Cancer Epidemiology and Genetics; and ⁶ Core Genotyping Facility, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, NIH, Bethesda, Maryland; and ⁷ Harvard School of Dental Medicine, Boston, Massachusetts

Requests for reprints: Sharon A. Savage, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, EPS/7018, Rockville, MD 20852. Phone: 301-496-5785; Fax: 301-496-1854. E-mail: savagesh{at}mail.nih.gov

Background: Osteosarcoma, the most common malignant primary bone tumor, typically occurs during the adolescent growth spurt. Germ-line genetic variation in genes critical in growth regulation could confer altered risk of osteosarcoma.

Methods: Fifty-two common single nucleotide polymorphisms (SNP) in 13 genes were genotyped in a prospective case-control study of osteosarcoma (104 osteosarcoma cases and 74 orthopedic controls). Genotype data analyzed with contingency tables suggested the strongest association with insulin-like growth factor 2 receptor (IGF2R) SNPs. Additional SNPs were genotyped to capture IGF2R common haplotypes and resequencing was done across the IGF2R block associated with osteosarcoma risk. Percentage methylation was determined by pyrosequencing of the IGF2R variant allele located in a CpG island.

Results: IGF2R Ex16+88G>A (rs998075) and IVS16+15C>T (rs998074) SNPs were associated with increased risk for osteosarcoma compared with orthopedic controls (haplotype odds ratio, 2.04; 95% confidence interval, 1.29-3.24). Follow-up genotyping showed that IGF2R IVS15+213C>T was also associated with increased osteosarcoma risk. Resequence analysis identified two additional SNPs linked to the risk-associated SNPs; linkage disequilibrium was strongest in a 1-kb pair region around them. The Ex16+88G>A SNP is located within a CpG island and alters methylation at that site.

Conclusion: This pilot study of germ-line genetic variation in growth pathway genes and osteosarcoma identified a haplotype block in IGF2R associated with increased risk of osteosarcoma. The presence of a SNP in this block results in loss of methylation at a CpG island, providing corroborative evidence of a possible functional variant. Our analysis of the IGF2R haplotype structure will be applicable to future studies of IGF2R and disease risk. (Cancer Epidemiol Biomarkers Prev 2007;16(8):1667–74)

This article has been cited by other articles:

				I. Cheng, D. O. Stram, N. P. Burtt, L. Gianniny, R. R. Garcia, L. Pooler, B. E. Henderson, L. Le Marchand, and C. A. Haiman IGF2R Missense Single-Nucleotide Polymorphisms and Breast Cancer Risk: The Multiethnic Cohort Study Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1922 - 1924. [Abstract] [Full Text] [PDF]

				D. Rezgui, C. Williams, S. A Savage, S. N Prince, O. J Zaccheo, E Y. Jones, M. P Crump, and A B. Hassan Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth J. Mol. Endocrinol., April 1, 2009; 42(4): 341 - 356. [Abstract] [Full Text] [PDF]

				H. Suzuki, Y. Li, X. Dong, M. M. Hassan, J. L. Abbruzzese, and D. Li Effect of Insulin-Like Growth Factor Gene Polymorphisms Alone or In Interaction with Diabetes on the Risk of Pancreatic Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3467 - 3473. [Abstract] [Full Text] [PDF]